Mitchell A. Hamman - Concepedia

Concepedia

Author

Mitchell A. Hamman

Indiana University – Purdue University Indianapolis

Also Known As

M A Hamman, M HAMMAN, M. A. Hamman, M. Hamman, M.A. Hamman, Mitchell A Hamman, Mitchell A. Hamman

25

Publications

2.5K

Citations

18

H-Index

29

Concepts

All Affiliations

Indiana University – Purdue University Indianapolis Indiana University School of Medicine Sidney & Lois Eskenazi Hospital Eli Lilly (United States)Indiana University

MA

About

Mitchell A. Hamman is an author at Indiana University – Purdue University Indianapolis specializing in biochemistry, pharmacology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	5	5	591
2	Medicine	4	4	481
3	Health Sciences	3	3	243
4	Natural Sciences	3	3	370
5	Gastroenterology	1	1	30

Mitchell A. Hamman

×

19

Publications

2.5K

Citations

18

H-Index

	Year	Citations
Comparative Metabolic Capabilities of CYP3A4, CYP3A5, and CYP3A7 J. Andrew Williams, Barbara J. Ring, Varon E. Cantrell, Drug Metabolism and Disposition	2002	463
The contribution of intestinal and hepatic CYP3A to the interaction between midazolam and clarithromycin* Jack Gorski, D. I. Jones, B HAEHNERDANIELS, Clinical Pharmacology & Therapeutics	1998	410
Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C Mitchell A. Hamman, Gary A. Thompson, Stephen D. Hall Biochemical Pharmacology Molecular PharmacologyMedicinal ChemistryPharmacological StudyBiochemistryMedicine	1997	230
Identification of the human cytochromes P450 responsible for the in vitro formation of the major oxidative metabolites of the antipsychotic agent olanzapine. Barbara J. Ring, John T. Catlow, Thomas J. Lindsay, Journal of Pharmacology and Experimental Therapeutics	1996	214
Effect of St John's wort on the pharmacokinetics of fexofenadine Zaiqi Wang, Mitchell A. Hamman, Shiew‐Mei Huang, Clinical Pharmacology & Therapeutics	2002	213
The effects of St John's wort <i>(Hypericum perforatum)</i> on human cytochrome P450 activity Zaiqi Wang, J. Christopher Gorski, Mitchell A. Hamman, Clinical Pharmacology & Therapeutics Hypericum PerforatumSeveral Cytochrome P450Secondary MetaboliteLong‐term St JohnPharmacotherapy	2001	167
Diltiazem Inhibition of Cytochrome P-450 3A Activity Is Due To Metabolite Intermediate Complex Formation David Jones, J. Christopher Gorski, Mitchell A. Hamman, Journal of Pharmacology and Experimental Therapeutics	1999	146
The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity. Zaiqi Wang, Mitchell A. Hamman, Shiew‐Mei Huang, PubMed	2001	124
Stereoselective sulfoxidation of sulindac sulfide by flavin-containing monooxygenases Mitchell A. Hamman, B HAEHNERDANIELS, Steven Wrighton, Biochemical Pharmacology Bioorganic ChemistryBiochemistryNatural SciencesSulindac SulfideDesulfurization	2000	94
Biotransformation of alprazolam by members of the human cytochrome P4503A subfamily J. Christopher Gorski, Drew R. Jones, Mitchell A. Hamman, Xenobiotica	1999	76

Page 1